KeyCorp Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its target price cut by equities researchers at KeyCorp from $420.00 to $370.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. KeyCorp’s price objective suggests a potential upside of 18.90% from the stock’s current price.

Other equities analysts have also recently issued research reports about the stock. Oppenheimer boosted their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Morgan Stanley dropped their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Finally, Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Stock Up 1.0 %

HCA opened at $311.19 on Tuesday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a market cap of $78.82 billion, a PE ratio of 13.97, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64. HCA Healthcare has a 12 month low of $276.50 and a 12 month high of $417.14. The company has a 50 day moving average of $323.68 and a 200 day moving average of $354.18.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

Institutional investors have recently modified their holdings of the company. Terra Nova Asset Management LLC boosted its position in shares of HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after buying an additional 26 shares during the period. Massmutual Trust Co. FSB ADV boosted its holdings in shares of HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after acquiring an additional 29 shares in the last quarter. Waldron Private Wealth LLC lifted its position in HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after purchasing an additional 29 shares during the period. Brookstone Capital Management raised its stake in shares of HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after buying an additional 30 shares in the last quarter. Finally, UMB Bank n.a. raised its position in HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after acquiring an additional 30 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.